Upstate Active Clinical Trials
Study Title:CALGB 50801-Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I And Stage II Classical Hodgkin Lymphoma (HL)
What is the purpose of the study?This phase II clinical trial is studying how well response-based therapy assessed by PET scan works in treating patients with bulky stage I and stage II Hodgkin lymphoma.
Upstate Institutional Review Board (IRB) Number:267123
Patient Age Group:Adults
Principal Investigator:Teresa C Gentile, MD, PhD
Who can I contact for more information?
Name: Virginia M Schutt, CCRP